Intuitive Surgical, Inc. Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
15.1%projected annual EPS growth
Analyst Coverage
30analysts covering
FY Revenue (est.)
$11.8Bnext fiscal year
FY EPS (est.)
$10.79next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Next Earnings Release | 20 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Worldwide da Vinci procedure growth, year over year (%) Quarterly15.0%Target: 2026 guidance: 13.5%-15.5%, with management expecting performance near the midpoint
Worldwide Ion procedure growth, year over year (%) Quarterly36.0%
Worldwide da Vinci installed base (systems) Quarterly11.7K
Quarterly da Vinci 5 system placements Quarterly246.0
Watch Items
- Full-year da Vinci procedure growth relative to management guidanceAction: Reassess procedure-demand assumptions and determine whether weakness reflects temporary scheduling effects or structural utilization pressure.
- Ion procedure-growth momentum relative to the latest reported quarterAction: Review Ion utilization, placements, geographic adoption, and competitive developments for evidence of sustained deceleration.
- da Vinci 5 placement momentum relative to the latest reported quarterAction: Examine leasing mix, hospital purchasing cycles, regulatory availability, and conversion from earlier da Vinci generations.
Research as of 29 Aug 2026